Search research articles
Contact Us
Filters
Showing results (181-190 of 288) with videos related to
Page
of 29
Sort By:
BMC Pediatrics
|
October 14, 2014
Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis
Leonard R Krilov, Anthony S Masaquel, Leonard B Weiner, et al.
British Journal of Pharmacology
|
June 28, 2002
Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines
Tejal Choksi, Debbie L Hay, Stephen Legon, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
The Art of Designing DNA Nanostructures with CAD Software
Martin Glaser, Sourav Deb, Florian Seier, et al.
Journal of the American Chemical Society
|
June 13, 2018
Computational Tale of Two Enzymes: Glycerol Dehydration With or Without B<sub>12</sub>
Borislav Kovačević, Danijela Barić, Darko Babić, et al.
Journal of the American Heart Association
|
October 30, 2016
Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
Jay M Margolis, Steven Deitelzweig, Jeffrey Kline, et al.
Clinical Therapeutics
|
October 19, 2016
Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin
Jay M Margolis, Steven Deitelzweig, Jeffrey Kline, et al.
Endocrinology
|
July 19, 2012
Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets
Hannah J Welters, Abdelfattah El Ouaamari, Dan Kawamori, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
September 26, 2012
Anticoagulant use, the prevalence of bridging, and relation to length of stay among hospitalized patients with non-valvular atrial fibrillation
Karen Smoyer-Tomic, Kimberly Siu, David R Walker, et al.
Scientific Reports
|
July 27, 2022
Characterization of binding interactions of SARS-CoV-2 spike protein and DNA-peptide nanostructures
Marlen Kruse, Basma Altattan, Eva-Maria Laux, et al.
Cardiovascular Diabetology
|
September 15, 2017
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Pia S Pollack, Kristina D Chadwick, David M Smith, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 288) with videos related to
Sort By:
Page
of 29
BMC Pediatrics
|
October 14, 2014
Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis
Leonard R Krilov, Anthony S Masaquel, Leonard B Weiner, et al.
British Journal of Pharmacology
|
June 28, 2002
Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines
Tejal Choksi, Debbie L Hay, Stephen Legon, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
The Art of Designing DNA Nanostructures with CAD Software
Martin Glaser, Sourav Deb, Florian Seier, et al.
Journal of the American Chemical Society
|
June 13, 2018
Computational Tale of Two Enzymes: Glycerol Dehydration With or Without B<sub>12</sub>
Borislav Kovačević, Danijela Barić, Darko Babić, et al.
Journal of the American Heart Association
|
October 30, 2016
Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
Jay M Margolis, Steven Deitelzweig, Jeffrey Kline, et al.
Clinical Therapeutics
|
October 19, 2016
Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin
Jay M Margolis, Steven Deitelzweig, Jeffrey Kline, et al.
Endocrinology
|
July 19, 2012
Rosiglitazone promotes PPARγ-dependent and -independent alterations in gene expression in mouse islets
Hannah J Welters, Abdelfattah El Ouaamari, Dan Kawamori, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
September 26, 2012
Anticoagulant use, the prevalence of bridging, and relation to length of stay among hospitalized patients with non-valvular atrial fibrillation
Karen Smoyer-Tomic, Kimberly Siu, David R Walker, et al.
Scientific Reports
|
July 27, 2022
Characterization of binding interactions of SARS-CoV-2 spike protein and DNA-peptide nanostructures
Marlen Kruse, Basma Altattan, Eva-Maria Laux, et al.
Cardiovascular Diabetology
|
September 15, 2017
Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
Pia S Pollack, Kristina D Chadwick, David M Smith, et al.
Page
of 29